Cargando…

Development and validation of a new clinical decision support tool to optimize screening for retinopathy of prematurity

BACKGROUND/AIMS: Prematurely born infants undergo costly, stressful eye examinations to uncover the small fraction with retinopathy of prematurity (ROP) that needs treatment to prevent blindness. The aim was to develop a prediction tool (DIGIROP-Screen) with 100% sensitivity and high specificity to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pivodic, Aldina, Johansson, Helena, Smith, Lois E H, Hård, Anna-Lena, Löfqvist, Chatarina, Yoder, Bradley A, Hartnett, M Elizabeth, Wu, Carolyn, Bründer, Marie-Christine, Lagrèze, Wolf A, Stahl, Andreas, Al-Hawasi, Abbas, Larsson, Eva, Lundgren, Pia, Gränse, Lotta, Sunnqvist, Birgitta, Tornqvist, Kristina, Wallin, Agneta, Holmström, Gerd, Albertsson-Wikland, Kerstin, Nilsson, Staffan, Hellström, Ann
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2022
Materias:	Clinical Science
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627649/ https://www.ncbi.nlm.nih.gov/pubmed/33980506 http://dx.doi.org/10.1136/bjophthalmol-2020-318719

Ejemplares similares

Prognostic Value of Parenteral Nutrition Duration on Risk of Retinopathy of Prematurity: Development and Validation of the Revised DIGIROP Clinical Decision Support Tool
por: Pivodic, Aldina, et al.
Publicado: (2023)

Validation of DIGIROP models and decision support tool for prediction of treatment for retinopathy of prematurity on a contemporary Swedish cohort
por: Pivodic, Aldina, et al.
Publicado: (2023)

Individual Risk Prediction for Sight-Threatening Retinopathy of Prematurity Using Birth Characteristics
por: Pivodic, Aldina, et al.
Publicado: (2019)

High rate and large intercentre variability in retreatment of retinopathy of prematurity in infants born <24 gestational weeks
por: Lundgren, Pia, et al.
Publicado: (2021)

Evaluation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) in a randomised controlled trial aiming for prevention of severe ROP: a substudy of the Mega Donna Mega trial
por: Pivodic, Aldina, et al.
Publicado: (2022)

Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants
por: Hellström, Ann, et al.
Publicado: (2021)

Retrospective evaluation of ophthalmological and neurological outcomes for infants born before 24 weeks gestational age in a Swedish cohort
por: Hellström, Ann, et al.
Publicado: (2022)

Unpasteurised maternal breast milk is positively associated with growth outcomes in extremely preterm infants
por: Lund, Anna‐My, et al.
Publicado: (2019)

Decreased Platelet Counts and Serum Levels of VEGF-A, PDGF-BB, and BDNF in Extremely Preterm Infants Developing Severe ROP
por: Hellgren, Gunnel, et al.
Publicado: (2021)

Visual outcome at 2.5 years of age in ω-3 and ω-6 long-chain polyunsaturated fatty acid supplemented preterm infants: a follow-up of a randomized controlled trial
por: Lundgren, Pia, et al.
Publicado: (2023)

WINROP Identifies Severe Retinopathy of Prematurity at an Early Stage in a Nation-Based Cohort of Extremely Preterm Infants
por: Lundgren, Pia, et al.
Publicado: (2013)

Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity
por: Lundgren, Pia, et al.
Publicado: (2017)

Validation of the Retinopathy of Prematurity Activity Scale (ROP-ActS) using retrospective clinical data
por: Pivodic, Aldina, et al.
Publicado: (2020)

Association between low fatty acid levels and platelet count in infants with Retinopathy of Prematurity
por: Lundgren, Pia, et al.
Publicado: (2020)

Low Birth Weight Is a Risk Factor for Severe Retinopathy of Prematurity Depending on Gestational Age
por: Lundgren, Pia, et al.
Publicado: (2014)

Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial
por: Sjöbom, Ulrika, et al.
Publicado: (2023)

Prevalence of Severe Visual Disability Among Preterm Children With Retinopathy of Prematurity and Association With Adherence to Best Practice Guidelines
por: Norman, Mikael, et al.
Publicado: (2019)

Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial
por: Hellström, Ann, et al.
Publicado: (2021)

Correspondence to “Prediction of severe retinopathy of prematurity in 24–30 weeks gestation infants using birth characteristics”
por: Pivodic, Aldina, et al.
Publicado: (2021)

Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: A randomized controlled trial
por: Najm, Svetlana, et al.
Publicado: (2017)

IGF-1 as a Drug for Preterm Infants: A Step-Wise Clinical Development
por: Hellström, Ann, et al.
Publicado: (2017)

Sphingolipidomics of serum in extremely preterm infants: Association between low sphingosine-1-phosphate levels and severe retinopathy of prematurity
por: Nilsson, Anders K., et al.
Publicado: (2021)

Increased postnatal concentrations of pro-inflammatory cytokines are associated with reduced IGF-I levels and retinopathy of prematurity
por: Hellgren, Gunnel, et al.
Publicado: (2017)

National cohort of infants born before 24 gestational weeks showed increased survival rates but no improvement in neonatal morbidity
por: Lundgren, Pia, et al.
Publicado: (2022)

Systematic review of the healthcare cost of bronchopulmonary dysplasia
por: Humayun, Jhangir, et al.
Publicado: (2021)

Costs associated with retinopathy of prematurity: a systematic review and meta-analysis
por: Gyllensten, Hanna, et al.
Publicado: (2022)

Analysis of Brain Injury Biomarker Neurofilament Light and Neurodevelopmental Outcomes and Retinopathy of Prematurity Among Preterm Infants
por: Sjöbom, Ulrika, et al.
Publicado: (2021)

Association of Retinopathy of Prematurity With Low Levels of Arachidonic Acid: A Secondary Analysis of a Randomized Clinical Trial
por: Löfqvist, Chatarina A., et al.
Publicado: (2018)

A systematic review and meta-analysis of preanalytical factors and methodological differences influencing the measurement of circulating vascular endothelial growth factor
por: Sjöbom, Ulrika, et al.
Publicado: (2022)

Low fraction of fetal haemoglobin is associated with retinopathy of prematurity in the very preterm infant
por: Hellström, William, et al.
Publicado: (2022)

Neonatal IGF-1/IGFBP-1 axis and retinopathy of prematurity are associated with increased blood pressure in preterm children
por: Kistner, Anna, et al.
Publicado: (2014)

Long‐chain polyunsaturated fatty acids decline rapidly in milk from mothers delivering extremely preterm indicating the need for supplementation
por: Nilsson, Anders K., et al.
Publicado: (2018)

Influence of Human Milk and Parenteral Lipid Emulsions on Serum Fatty Acid Profiles in Extremely Preterm Infants
por: Nilsson, Anders K., et al.
Publicado: (2018)

FGF21 via mitochondrial lipid oxidation promotes physiological vascularization in a mouse model of Phase I ROP
por: Fu, Zhongjie, et al.
Publicado: (2023)

IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants
por: Cakir, Bertan, et al.
Publicado: (2020)

Insulin‐like growth factor 1 has multisystem effects on foetal and preterm infant development
por: Hellström, Ann, et al.
Publicado: (2016)

Continuous growth reference from 24(th )week of gestation to 24 months by gender
por: Niklasson, Aimon, et al.
Publicado: (2008)

GH Responsiveness in Children With Noonan Syndrome Compared to Turner Syndrome
por: Dahlgren, Jovanna, et al.
Publicado: (2021)

Neurodevelopmental disorders and somatic diagnoses in a national cohort of children born before 24 weeks of gestation
por: Morsing, Eva, et al.
Publicado: (2022)

Serum choline in extremely preterm infants declines with increasing parenteral nutrition
por: Nilsson, Anders K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f2a2ep35v8mdq2q1kossp00jgd